Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arad

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cardioscience|December 1, 1994
Adenosine, added to St Thomas' Hospital cardioplegic solution, improves functional recovery and reduces irreversible myocardial damageC van der Lee, T Huizer, M Janssen, et al.
American Heart Journal|March 27, 2001
Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national studyA Shotan, S Gottlieb, U Goldbourt, et al.
Medical Engineering & Physics|March 21, 2006
A portable bio-impedance system for monitoring lung resistivityS Zlochiver, M Arad, M M Radai, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 16, 2003
Molecular epidemiology of hypertrophic cardiomyopathyH Morita, S R DePalma, M Arad, et al.
Cardiovascular Diabetology|January 12, 2020
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathyM Arow, M Waldman, D Yadin, et al.
EJNMMI Research|September 6, 2021
Quantitative SPECT/CT parameters of myocardial <sup>99m</sup>Technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosisSimona Ben-Haim, A Chicheportiche, E Goshen, et al.
Cardiovascular Pharmacology: Open Access|May 1, 2018
CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy <i>via</i> PGC-1 <i>α</i> ActivationS P Singh, J A McClung, L Bellner, et al.
Lupus|June 1, 1996
Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valvesL Ziporen, I Goldberg, M Arad, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cardioscience|December 1, 1994
Adenosine, added to St Thomas' Hospital cardioplegic solution, improves functional recovery and reduces irreversible myocardial damageC van der Lee, T Huizer, M Janssen, et al.
American Heart Journal|March 27, 2001
Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national studyA Shotan, S Gottlieb, U Goldbourt, et al.
Medical Engineering & Physics|March 21, 2006
A portable bio-impedance system for monitoring lung resistivityS Zlochiver, M Arad, M M Radai, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 16, 2003
Molecular epidemiology of hypertrophic cardiomyopathyH Morita, S R DePalma, M Arad, et al.
Cardiovascular Diabetology|January 12, 2020
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathyM Arow, M Waldman, D Yadin, et al.
EJNMMI Research|September 6, 2021
Quantitative SPECT/CT parameters of myocardial <sup>99m</sup>Technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosisSimona Ben-Haim, A Chicheportiche, E Goshen, et al.
Cardiovascular Pharmacology: Open Access|May 1, 2018
CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy <i>via</i> PGC-1 <i>α</i> ActivationS P Singh, J A McClung, L Bellner, et al.
Lupus|June 1, 1996
Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valvesL Ziporen, I Goldberg, M Arad, et al.
Pageof 7